Evidence map›Paper›PMID 25006153›Full record

ArticleHealth affairs (Project Hope)2014

Genomic sequencing: assessing the health care system, policy, and big-data implications.

Kathryn A Phillips, Julia R Trosman, Robin K Kelley, Mark J Pletcher, Michael P Douglas, Christine B Weldon

Abstract read
In one paragraph

Article in Health affairs (Project Hope), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2020
    Trial
  3. Observational
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Outcomes of prior authorization requests for genetic testing in outpatient pediatric genetics clinics.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  13. Article
  14. Article
  15. Economic evaluations of big data analytics for clinical decision-making: a scoping review.Journal of the American Medical Informatics Association : JAMIA · 2020
    Article
  16. Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2020
    Article
  17. Article
  18. Review
  19. Review
  20. A Data Adaptive Biological Sequence Representation for Supervised Learning.Journal of healthcare informatics research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kathryn A PhillipsKathryn A. Phillips (PhillipsK@pharmacy.ucsf.edu) is a professor in the Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), the Department of Clinical Pharmacy, the Philip R. Lee Institute for Health Policy, and the Helen Diller Family Comprehensive Cancer Center, all at the University of California, San Francisco (UCSF).
Julia R TrosmanJulia R. Trosman is codirector of the Center for Business Models in Healthcare, in Chicago, Illinois, and an adjunct faculty member in the Department of Clinical Pharmacy, UCSF.
Robin K KelleyRobin K. Kelley is an assistant clinical professor in the Department of Medicine, Division of Hematology/Oncology, UCSF.
Mark J PletcherMark J. Pletcher is an associate professor in the Department of Epidemiology and Biostatistics and the Department of Medicine, UCSF.
Michael P DouglasMichael P. Douglas is a program manager in TRANSPERS and the Department of Clinical Pharmacy, UCSF.
Christine B WeldonChristine B. Weldon is codirector of the Center for Business Models in Healthcare and an adjunct faculty member in the Feinberg School of Medicine, Northwestern University, in Chicago.

Funding

Risk-Benefit Trade-Offs for Whole Genome SequencingR01HG007063 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PHILLIPS, KATHRYN A · 2013 to 2016
$2.5M
PHOTOPRODUCTION OF MEDICAL RADIOISOTOPESR43CA082013 · NCI · WORLD PHYSICS TECHNOLOGIES, INC. · PI KNAPP, EDWARD A · 1999 to 1999
–
NCI NIH HHS 5P30CA082013-15NHGRI NIH HHS R01 HG007063NHGRI NIH HHS R01HG007063
6 · The paper itself

Abstract

New genomic sequencing technologies enable the high-speed analysis of multiple genes simultaneously, including all of those in a person's genome. Sequencing is a prominent example of a "big data" technology because of the massive amount of information it produces and its complexity, diversity, and timeliness. Our objective in this article is to provide a policy primer on sequencing and illustrate how it can affect health care system and policy issues. Toward this end, we developed an easily applied classification of sequencing based on inputs, methods, and outputs. We used it to examine the implications of sequencing for three health care system and policy issues: making care more patient-centered, developing coverage and reimbursement policies, and assessing economic value. We conclude that sequencing has great promise but that policy challenges include how to optimize patient engagement as well as privacy, develop coverage policies that distinguish research from clinical uses and account for bioinformatics costs, and determine the economic value of sequencing through complex economic models that take into account multiple findings and downstream costs.

Indexed as

Delivery of Health CareGenomicsData MiningDatasets as TopicGenetic TestingHealth Care CostsHealth PolicyHumansInsurance CoverageModels, EconomicSequence Analysis, DNACost of Health CareHealth EconomicsInformation TechnologyInsurance Coverage < InsuranceMedical technology

Identifiers

PMID25006153
PMCPMC4113721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.